Anders Borde

699 total citations
9 papers, 550 citations indexed

About

Anders Borde is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anders Borde has authored 9 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 2 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anders Borde's work include Drug Solubulity and Delivery Systems (4 papers), Gastrointestinal motility and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Anders Borde is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Gastrointestinal motility and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Anders Borde collaborates with scholars based in Sweden, United Kingdom and United States. Anders Borde's co-authors include Christer Tannergren, Mareike Lutz, Anna‐Lena Ungell, Åsa Sjöberg, Bertil Abrahamsson, Vipul Yadav, Tiago Sousa, Abdul W. Basit, Jennifer Dressman and René Holm and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and European Journal of Pharmaceutical Sciences.

In The Last Decade

Anders Borde

8 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Borde Sweden 6 241 148 137 70 63 9 550
Betty Lomstein Pedersen Denmark 9 462 1.9× 192 1.3× 108 0.8× 149 2.1× 80 1.3× 11 666
Hosnieh Tajerzadeh Iran 14 230 1.0× 240 1.6× 102 0.7× 18 0.3× 61 1.0× 36 792
André Huss Eriksson Denmark 12 164 0.7× 99 0.7× 96 0.7× 25 0.4× 45 0.7× 17 487
Babita Garg India 13 390 1.6× 97 0.7× 32 0.2× 36 0.5× 58 0.9× 17 597
Josef J. Tukker Netherlands 11 406 1.7× 170 1.1× 199 1.5× 17 0.2× 30 0.5× 14 674
Katja Berginc Slovenia 15 240 1.0× 121 0.8× 94 0.7× 64 0.9× 34 0.5× 28 601
Rajesh Kesarla India 8 354 1.5× 154 1.0× 26 0.2× 48 0.7× 33 0.5× 10 579
Seh Hyon Song South Korea 12 314 1.3× 75 0.5× 29 0.2× 69 1.0× 40 0.6× 16 447
Ahmed N. Allam Egypt 16 225 0.9× 160 1.1× 28 0.2× 38 0.5× 21 0.3× 24 574
Shadeed Gad Egypt 15 408 1.7× 127 0.9× 24 0.2× 34 0.5× 24 0.4× 71 624

Countries citing papers authored by Anders Borde

Since Specialization
Citations

This map shows the geographic impact of Anders Borde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Borde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Borde more than expected).

Fields of papers citing papers by Anders Borde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Borde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Borde. The network helps show where Anders Borde may publish in the future.

Co-authorship network of co-authors of Anders Borde

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Borde. A scholar is included among the top collaborators of Anders Borde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Borde. Anders Borde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Engman, Helena, Sara Carlert, Richard A. Barker, et al.. (2025). Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies. Molecular Pharmaceutics. 22(10). 6203–6214. 1 indexed citations
2.
Sousa, Tiago, et al.. (2025). Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism. European Journal of Pharmaceutical Sciences. 214. 107273–107273.
3.
Avdeef, Alex, et al.. (2023). A comparison of USP 2 and µDISS Profiler™ apparatus for studying dissolution phenomena of ibuprofen and its salts. European Journal of Pharmaceutical Sciences. 193. 106684–106684. 2 indexed citations
4.
Abrahmsén‐Alami, Susanna, et al.. (2020). Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization. Pharmaceutics. 12(8). 771–771. 15 indexed citations
5.
Sousa, Tiago, et al.. (2014). On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid. Journal of Pharmaceutical Sciences. 103(10). 3171–3175. 97 indexed citations
6.
Tannergren, Christer, et al.. (2013). Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans. European Journal of Pharmaceutical Sciences. 57. 200–206. 23 indexed citations
7.
Bergström, Christel A. S., René Holm, Sara Andersson, et al.. (2013). Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. European Journal of Pharmaceutical Sciences. 57. 173–199. 206 indexed citations
8.
Sjöberg, Åsa, et al.. (2012). Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. European Journal of Pharmaceutical Sciences. 48(1-2). 166–180. 174 indexed citations
9.
Marie-Magdeleine, Carine, et al.. (2010). Effect of banana foliage (Musa x paradisiaca) on nutrition, parasite infection and growth of lambs. Livestock Science. 131(2-3). 234–239. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026